Kestra Medical Technologies (KMTS) Competitors $16.14 -1.57 (-8.87%) As of 08/29/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KMTS vs. SLNO, NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, AORT, and EYEShould you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), and National Vision (EYE). These companies are all part of the "medical equipment" industry. Kestra Medical Technologies vs. Its Competitors Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion National Vision Kestra Medical Technologies (NASDAQ:KMTS) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Does the media favor KMTS or SLNO? In the previous week, Soleno Therapeutics had 16 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 24 mentions for Soleno Therapeutics and 8 mentions for Kestra Medical Technologies. Soleno Therapeutics' average media sentiment score of 0.97 beat Kestra Medical Technologies' score of 0.97 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 12 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of KMTS or SLNO? 97.4% of Soleno Therapeutics shares are owned by institutional investors. 3.6% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 6.4% of Soleno Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable valuation and earnings, KMTS or SLNO? Kestra Medical Technologies has higher revenue and earnings than Soleno Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKestra Medical Technologies$59.82M13.86-$113.81MN/AN/ASoleno TherapeuticsN/AN/A-$175.85M-$4.14-16.35 Is KMTS or SLNO more profitable? Kestra Medical Technologies' return on equity of 0.00% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Kestra Medical TechnologiesN/A N/A N/A Soleno Therapeutics N/A -73.74%-56.67% Do analysts prefer KMTS or SLNO? Kestra Medical Technologies presently has a consensus target price of $27.33, suggesting a potential upside of 69.35%. Soleno Therapeutics has a consensus target price of $115.09, suggesting a potential upside of 70.08%. Given Soleno Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Soleno Therapeutics is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08 SummarySoleno Therapeutics beats Kestra Medical Technologies on 8 of the 12 factors compared between the two stocks. Get Kestra Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KMTS vs. The Competition Export to ExcelMetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$909.39M$10.77B$5.66B$9.84BDividend YieldN/A1.85%3.93%4.04%P/E RatioN/A21.7983.2726.61Price / Sales13.8631.71451.26176.46Price / CashN/A24.7237.7059.65Price / Book4.043.4810.556.59Net Income-$113.81M$211.94M$3.27B$266.12M7 Day Performance-13.13%1.47%0.47%0.17%1 Month Performance-3.18%13.90%5.93%3.03%1 Year PerformanceN/A-7.79%48.79%19.98% Kestra Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KMTSKestra Medical Technologies1.2524 of 5 stars$16.14-8.9%$27.33+69.4%N/A$909.39M$59.82M0.00300News CoveragePositive NewsLockup ExpirationSLNOSoleno Therapeutics4.5063 of 5 stars$68.25-2.2%$115.09+68.6%+45.3%$3.63B$32.66M-16.4830News CoverageAnalyst ForecastNVSTEnvista3.882 of 5 stars$21.67+5.9%$20.92-3.4%+14.9%$3.60B$2.51B67.7412,300News CoverageAnalyst DowngradeLIVNLivaNova1.7269 of 5 stars$55.88+5.7%$59.71+6.9%+12.2%$3.05B$1.25B-14.352,900Positive NewsWRBYWarby Parker2.0947 of 5 stars$27.03+3.7%$24.06-11.0%+74.8%$2.84B$771.32M-386.163,780News CoveragePositive NewsAnalyst UpgradeINSPInspire Medical Systems4.9821 of 5 stars$95.34+4.1%$165.62+73.7%-48.8%$2.82B$802.80M55.101,246Positive NewsLQDALiquidia Technologies3.5758 of 5 stars$26.81-1.8%$32.11+19.8%+190.1%$2.31B$19.32M-15.8050Positive NewsPRCTPROCEPT BioRobotics3.485 of 5 stars$41.22+4.8%$74.88+81.6%-49.0%$2.29B$224.50M-26.56430LMATLeMaitre Vascular2.6381 of 5 stars$100.63+4.3%$97.60-3.0%+7.6%$2.28B$219.86M48.85490Positive NewsAORTArtivion3.2118 of 5 stars$44.87+4.0%$40.63-9.4%+63.3%$2.12B$388.54M-106.921,600Insider TradeEYENational Vision2.8888 of 5 stars$24.56+2.2%$24.73+0.7%+118.3%$1.95B$1.89B-136.5813,411Positive NewsInsider Trade Related Companies and Tools Related Companies SLNO Alternatives NVST Alternatives LIVN Alternatives WRBY Alternatives INSP Alternatives LQDA Alternatives PRCT Alternatives LMAT Alternatives AORT Alternatives EYE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KMTS) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
